NIH to evaluate remdesivir treatment for COVID during pregnancy
Por um escritor misterioso
Descrição
WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]
Remdesivir for pregnancy: A systematic review of antiviral therapy
Summary of Guidance for Minimizing the Impact of COVID-19 on
Remdesivir COVID-19 Treatment Guidelines
Covid-19 Research Opens to Little-Studied Group: Pregnant Patients
2020 Archive - UM School of Medicine Researchers Test Remdesivir
Therapeutic Management of Nonhospitalized Adults With COVID-19
SARS-CoV-2 infection in pregnancy: A systematic review and meta
Remdesivir Now Approved for COVID Outpatients, Too
COVID-19 Outpatient Therapeutics
NIH Coronavirus Funding
Clinical outcomes of hospitalized COVID-19 patients treated with
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid
Studies, Emory University
de
por adulto (o preço varia de acordo com o tamanho do grupo)
